Cathepsin B in osteoarthritis: cytochemical and histochemical analysis of human femoral head cartilage.

A Baici, A Lang, D Hörler, R Kissling, C Merlin

Department of Rheumatology, University Hospital, Zurich, Switzerland.

OBJECTIVE--To localise the cysteine endopeptidase cathepsin B in chondrocytes and cartilage from normal and osteoarthritic (OA) human femoral heads in order to provide qualitative information on its cellular expression and distribution at possible sites of action. METHODS--OA articular cartilage was obtained at surgery for total hip replacement; control cartilage was obtained at postmortem. Chondrocytes were isolated by sequential enzymatic digestion and cathepsin B analysed by immunocytochemistry and activity staining with a fluorogenic substrate. Lysosomes were visualised by fluorescence microscopy after staining of living cells with acridine orange. Using a histochemical reaction, enzyme activity was measured in cryosections of full thickness cartilage. RESULTS--Chondrocytes from normal cartilage contained very few lysosomes and only a minor cell population was cathepsin B positive. A high proportion of chondrocytes from active OA cartilage contained a large number of lysosomes and an excess of cathepsin B in intracellular organelles; the enzyme was stored in an active form. In this respect, OA chondrocytes closely resembled normal cells that had been phenotypically modulated by serial subcultures. No cathepsin B activity could be detected by histochemistry in either chondrocytes or matrix of normal cartilage. While apparently intact and severely degraded OA cartilage was also cathepsin B negative, tissue at sites of active destruction and, particularly, at repair sites was highly positive. CONCLUSION--The presence and the particular distribution of active cathepsin B in OA cartilage at 'more involved' sites suggest a pathological role for this enzyme in sustaining and perpetuating cartilage degradation. While other stimuli may also be responsible for cathepsin B expression in OA chondrocytes, the similarity with artificially modulated cells indicates fibroblastic metaplasia as a plausible mechanism.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Ruettger, A., Schueler, S., Mollenhauer, J. A., Wiederanders, B. (2008). Cathepsins B, K, and L Are Regulated by a Defined Collagen Type II Peptide via Activation of Classical Protein Kinase C and p38 MAP Kinase in Articular Chondrocytes. J. Biol. Chem. 283: 1043-1051 [Abstract] [Full Text]  
• Caglic, D., Pungercar, J. R., Pejler, G., Turk, V., Turk, B. (2007). Glycosaminoglycans Facilitate Procathepsin B Activation through Disruption of Propeptide-Mature Enzyme Interactions. J. Biol. Chem. 282: 33076-33085 [Abstract] [Full Text]  
• Muntener, K., Zwicky, R., Csucs, G., Rohrer, J., Baici, A. (2004). Exon Skipping of Cathepsin B: MITOCHONDRIAL TARGETING OF A LYSOSOMAL PEPTIDASE PROVOKES CELL DEATH. J. Biol. Chem. 279: 41012-41017 [Abstract] [Full Text]  
• Morko, J P, Soderstrom, M, Saamanen, A-M K, Salminen, H J, Vuorio, E I (2004). Up regulation of cathepsin K expression in articular chondrocytes in a transgenic mouse model for osteoarthritis. Ann Rheum Dis 63: 649-655 [Abstract] [Full Text]  
• Moran, M. T., Schofield, J. P., Hayman, A. R., Shi, G.-P., Young, E., Cox, T. M. (2000). Pathologic gene expression in Gaucher disease: up-regulation of cysteine proteinases including osteoclastic cathepsin K. Blood 96: 1969-1978 [Abstract] [Full Text]  
• BUCKWALTER, J. A., MANKIN, H. J. (1997). Instructional Course Lectures, The American Academy of Orthopaedic Surgeons - Articular Cartilage. Part II: Degeneration and Osteoarthrosis, Repair, Regeneration, and Transplantation*{{dagger}}. JBJS 79: 612-32 [Full Text]  
• Mehraban, F., Tindal, M. H, Proffitt, M. M, Moskowitz, R. W (1997). Temporal pattern of cysteine endopeptidase (cathepsin B) expression in cartilage and synovium from rabbit knees with experimental osteoarthritis: gene expression in chondrocytes in response to interleukin-1 and matrix depletion. Ann Rheum Dis 56: 108-115 [Abstract] [Full Text]